Levi & Korsinsky is investigating the Board of Directors of Cadence
Pharmaceuticals Inc. (“Cadence” or “the Company”) (NasdaqGS:CADX) for
possible breaches of fiduciary duty and other violations of state law in
connection with the sale of the Company to Mallinckrodt plc.
Click here to learn more about the action http://zlk.9nl.com/cadence-pharmaceuticals-cadx,
or call: 877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, Cadence shareholders will receive
$14.00 for each share of Cadence common stock they own. The
investigation concerns whether the Cadence Board breached their
fiduciary duties to stockholders by failing to adequately shop the
Company before agreeing to enter into this transaction, and whether
Mallinckrodt plc is underpaying for Cadence shares. In particular, at
least one analyst set a price target for Cadence stock at $15.00 per
share.
If you own Cadence common stock and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com
or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/cadence-pharmaceuticals-cadx.
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, Connecticut and Washington D.C. The firm’s 26 attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. For more information, please feel
free to contact any of the attorneys listed below. Attorney advertising.
Prior results do not guarantee similar outcomes.
Copyright Business Wire 2014